Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review

Keyphrases

• Pancreatic Ductal Adenocarcinoma 100%
• Neoadjuvant Therapy 100%
• Narrative Review 100%
• Pathologic Evaluation 100%
• Tumor Size 37%
• Grading System 37%
• Tumor Response Grade 37%
• Tumor 25%
• College of American Pathologists 25%
• Pathologic Assessment 25%
• MD Anderson Cancer Center 12%
• Author Experience 12%
• Prognostic Value 12%
• Histologic 12%
• Interobserver Agreement 12%
• Immunohistochemical Markers 12%
• Tumor Response 12%
• Published Data 12%
• Lymph Node 12%
• Patient Prognosis 12%
• Fibrosis 12%
• Molecular Markers 12%
• English Literature 12%
• PubMed 12%
• Radiology 12%
• Web of Science 12%
• Patient Care 12%
• Pancreatectomy 12%
• Pancreatic Tissue 12%
• Sampling Methods 12%
• Heterogeneous Tumors 12%
• Optimal Care 12%
• Optimal Sampling 12%
• Google Scholar 12%
• Artificial Intelligence 12%
• Pancreatobiliary 12%
• Personalized Care 12%
• Optimal Integration 12%
• Histopathology 12%
• Potentially Resectable 12%
• Resectable Pancreatic Adenocarcinoma 12%

Medicine and Dentistry

• Neoplasm 100%
• Pancreas Adenocarcinoma 100%
• Neoadjuvant Therapy 100%
• Malignant Neoplasm 22%
• Pathologist 22%
• Lymph Node 11%
• Histopathology 11%
• Patient Care 11%
• Fibrosis 11%
• Radiology 11%
• Pancreatic Ductal Adenocarcinoma 11%
• Pancreatectomy 11%
• Artificial Intelligence 11%